Skip to main content

Advertisement

SpringerLink
Log in

Management of Malignant Pleural Effusion

  • Published:
Lung Aims and scope Submit manuscript

Abstract

Malignancy is one of the most common causes of pleural effusion. Malignant pleural effusion is defined by the presence of malignant cells in the pleural fluid. Development of malignant pleural effusion usually defines advanced malignancy. Pathophysiology of malignant pleural effusion is not fully understood and may involve complex interactions between the mesothelial and malignant cells. Investigations and management of patients with malignant pleural effusion require a multidisciplinary approach. In this review, current practice for management of patients with malignant pleural effusion will be discussed. In addition, imaging techniques will be covered, including the use of thoracic ultrasound and its role in image-guiding pleural procedures. Moreover, interventional techniques will be described, such as medical thoracoscopy, the use of indwelling pleural catheters, or surgery for investigation and management of malignant pleural effusion.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Light RW (2011) Pleural effusions. Med Clin North Am 95(6):1055–1070

    Article  PubMed  Google Scholar 

  2. Bennett R, Maskell N (2005) Management of malignant pleural effusions. Curr Opin Pulm Med 11(4):296–300

    PubMed  Google Scholar 

  3. Shaw P, Agarwal R (2005) Pleurodesis for malignant pleural effusions. Cochrane Database Syst Rev (1):CD002916

  4. Heffner JE (2010) Management of the patient with a malignant pleural effusion. Semin Respir Crit Care Med 31(6):723–733

    Article  PubMed  Google Scholar 

  5. Awasthi A, Gupta N, Srinivasan R, Nijhawan R, Rajwanshi A (2007) Cytopathological spectrum of unusual malignant pleural effusions at a tertiary care centre in north India. Cytopathology 18(1):28–32

    Article  PubMed  CAS  Google Scholar 

  6. Heffner JE (2008) Diagnosis and management of malignant pleural effusions. Respirology 13(1):5–20

    PubMed  Google Scholar 

  7. Heffner JE, Klein JS (2008) Recent advances in the diagnosis and management of malignant pleural effusions. Mayo Clin Proc 83(2):235–250

    PubMed  Google Scholar 

  8. Roberts ME, Neville E, Berrisford RG, Antunes G, Ali NJ (2010) Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010. Thorax 65(Suppl 2):ii32–ii40

    Article  PubMed  Google Scholar 

  9. Burrows CM, Mathews WC, Colt HG (2000) Predicting survival in patients with recurrent symptomatic malignant pleural effusions: an assessment of the prognostic values of physiologic, morphologic, and quality of life measures of extent of disease. Chest 117(1):73–78

    Article  PubMed  CAS  Google Scholar 

  10. Fernandez C, Martin C, Aranda I, Romero S (2000) Malignant transient pleural transudate: a sign of early lymphatic tumoral obstruction. Respiration 67(3):333–336

    Article  PubMed  CAS  Google Scholar 

  11. Estenne M, Yernault JC, De Troyer A (1983) Mechanism of relief of dyspnea after thoracocentesis in patients with large pleural effusions. Am J Med 74(5):813–819

    Article  PubMed  CAS  Google Scholar 

  12. Judson MA, Sahn SA (1995) Pulmonary physiologic abnormalities caused by pleural disease. Semin Respir Respir Crit Care Med 16:346–353

    Article  Google Scholar 

  13. Wang JS, Tseng CH (1995) Changes in pulmonary mechanics and gas exchange after thoracentesis on patients with inversion of a hemidiaphragm secondary to large pleural effusion. Chest 107(6):1610–1614

    Article  PubMed  CAS  Google Scholar 

  14. Light RW, Stansbury DW, Brown SE (1986) The relationship between pleural pressures and changes in pulmonary function after therapeutic thoracentesis. Am Rev Respir Dis 133(4):658–661

    PubMed  CAS  Google Scholar 

  15. Lee YC, Light RW, Musk AW (2000) Management of malignant pleural mesothelioma: a critical review. Curr Opin Pulm Med 6(4):267–274

    Article  PubMed  CAS  Google Scholar 

  16. Bech C, Sorensen JB (2008) Polyneuropathy in a patient with malignant pleural mesothelioma: a paraneoplastic syndrome. J Thorac Oncol 3(11):1359–1360

    Article  PubMed  Google Scholar 

  17. Kashyap AS, Kashyap S (2001) An elderly man with pleural effusion and abnormal behaviour. Postgrad Med J 77(908):407–413

    Article  PubMed  CAS  Google Scholar 

  18. Banayan S, Hot A, Janier M, Ninet J, Zurlinden O, Billotey C (2006) Malignant mesothelioma of the peritoneum as the cause of a paraneoplastic syndrome: detection by 18F-FDG PET. Eur J Nucl Med Mol Imaging 33(6):751

    Article  PubMed  Google Scholar 

  19. Perks WH, Crow JC, Green M (1978) Mesothelioma associated with the syndrome of inappropriate secretion of antidiuretic hormone. Am Rev Respir Dis 117(4):789–794

    PubMed  CAS  Google Scholar 

  20. Balduyck B, Lauwers P, Govaert K, Hendriks J, De Maeseneer M, Van Schil P (2006) Solitary fibrous tumor of the pleura with associated hypoglycemia: Doege–Potter syndrome: a case report. J Thorac Oncol 1(6):588–590

    Article  PubMed  Google Scholar 

  21. Beck JM (1998) Pleural disease in patients with acquired immune deficiency syndrome. Clin Chest Med 19(2):341–349

    Article  PubMed  CAS  Google Scholar 

  22. Afessa B (2000) Pleural effusion and pneumothorax in hospitalized patients with HIV infection: the Pulmonary Complications, ICU support, and Prognostic Factors of Hospitalized Patients with HIV (PIP) Study. Chest 117(4):1031–1037

    Article  PubMed  CAS  Google Scholar 

  23. Afessa B (2001) Pleural effusions and pneumothoraces in AIDS. Curr Opin Pulm Med 7(4):202–209

    Article  PubMed  CAS  Google Scholar 

  24. Porcel JM, Civit MC, Bielsa S, Light RW (2012) Contarini’s syndrome: bilateral pleural effusion, each side from different causes. J Hosp Med 7(2):164–165

    Article  PubMed  Google Scholar 

  25. Lawton F, Blackledge G, Johnson R (1985) Co-existent chylous and serous pleural effusions associated with ovarian cancer: a case report of Contarini’s syndrome. Eur J Surg Oncol 11(2):177–178

    PubMed  CAS  Google Scholar 

  26. Kutty CP, Varkey B (1978) “Contarini’s condition:” bilateral pleural effusions with markedly different characteristics. Chest 74(6):679–680

    Article  PubMed  CAS  Google Scholar 

  27. McGrath EE, Anderson PB (2011) Diagnosis of pleural effusion: a systematic approach. Am J Crit Care 20(2):119–127

    Article  PubMed  Google Scholar 

  28. Lee YC, Light RW (2004) Management of malignant pleural effusions. Respirology 9(2):148–156

    Article  PubMed  Google Scholar 

  29. Hooper C, Lee YC, Maskell N (2010) Investigation of a unilateral pleural effusion in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax 65(Suppl 2):ii4–17

    Article  PubMed  Google Scholar 

  30. Koenig SJ, Narasimhan M, Mayo PH (2011) Thoracic ultrasonography for the pulmonary specialist. Chest 140(5):1332–1341

    Article  PubMed  Google Scholar 

  31. Mayo PH, Doelken P (2006) Pleural ultrasonography. Clin Chest Med 27(2):215–227

    Article  PubMed  Google Scholar 

  32. Kastelik JA, Alhajji M, Faruqi S, Teoh R, Arnold AG (2009) Thoracic ultrasound: an important skill for respiratory physicians. Thorax 64(9):825–826

    Article  PubMed  CAS  Google Scholar 

  33. Qureshi NR, Rahman NM, Gleeson FV (2009) Thoracic ultrasound in the diagnosis of malignant pleural effusion. Thorax 64(2):139–143

    Article  PubMed  CAS  Google Scholar 

  34. Havelock T, Teoh R, Laws D, Gleeson F (2010) Pleural procedures and thoracic ultrasound: British Thoracic Society Pleural Disease Guideline 2010. Thorax 65(Suppl 2):ii61–ii76

    Article  PubMed  Google Scholar 

  35. Duncan DR, Morgenthaler TI, Ryu JH, Daniels CE (2009) Reducing iatrogenic risk in thoracentesis: establishing best practice via experiential training in a zero-risk environment. Chest 135(5):1315–1320

    Article  PubMed  Google Scholar 

  36. Barnes TW, Morgenthaler TI, Olson EJ, Hesley GK, Decker PA, Ryu JH (2005) Sonographically guided thoracentesis and rate of pneumothorax. J Clin Ultrasound 33(9):442–446

    Article  PubMed  Google Scholar 

  37. Seneff MG, Corwin RW, Gold LH, Irwin RS (1986) Complications associated with thoracocentesis. Chest 90(1):97–100

    Article  PubMed  CAS  Google Scholar 

  38. Jones PW, Moyers JP, Rogers JT, Rodriguez RM, Lee YC, Light RW (2003) Ultrasound-guided thoracentesis: is it a safer method? Chest 123(2):418–423

    Article  PubMed  Google Scholar 

  39. Wrightson JM, Helm EJ, Rahman NM, Gleeson FV, Davies RJ (2009) Pleural procedures and pleuroscopy. Respirology 14(6):796–807

    Article  PubMed  Google Scholar 

  40. Heidecker J, Huggins JT, Sahn SA, Doelken P (2006) Pathophysiology of pneumothorax following ultrasound-guided thoracentesis. Chest 130(4):1173–1184

    Article  PubMed  Google Scholar 

  41. Rahman NM, Singanayagam A, Davies HE, Wrightson JM, Mishra EK, Lee YC et al (2010) Diagnostic accuracy, safety and utilisation of respiratory physician-delivered thoracic ultrasound. Thorax 65(5):449–453

    Article  PubMed  Google Scholar 

  42. Hooper CE, Lee YC, Maskell NA (2010) Setting up a specialist pleural disease service. Respirology 15(7):1028–1036

    Article  PubMed  Google Scholar 

  43. Erasmus JJ, McAdams HP, Rossi SE, Goodman PC, Coleman RE, Patz EF (2010) FDG PET of pleural effusions in patients with non-small cell lung cancer. AJR Am J Roentgenol 175(1):245–249

    Article  Google Scholar 

  44. Truong MT, Viswanathan C, Erasmus JJ (2011) Positron emission tomography/computed tomography in lung cancer staging, prognosis, and assessment of therapeutic response. J Thorac Imaging 26(2):132–146

    Article  PubMed  Google Scholar 

  45. Gill RR (2011) Imaging of mesothelioma. Recent Results Cancer Res 189:27–43

    Article  PubMed  Google Scholar 

  46. Genestreti G, Moretti A, Piciucchi S, Giovannini N, Galassi R, Scarpi E et al (2012) FDG PET/CT response evaluation in malignant pleural mesothelioma patients treated with talc pleurodesis and chemotherapy. J Cancer 3:241–245

    Article  PubMed  Google Scholar 

  47. Duranti L, Leo F, Pastorino U (2012) PET scan contribution in chest tumor management: a systematic review for thoracic surgeons. Tumori 98(2):175–184

    PubMed  Google Scholar 

  48. Helm EJ, Matin TN, Gleeson FV (2010) Imaging of the pleura. J Magn Reson Imaging 32(6):1275–1286

    Article  PubMed  Google Scholar 

  49. Leung AN, Muller NL, Miller RR (1990) CT in differential diagnosis of diffuse pleural disease. AJR Am J Roentgenol 154(3):487–492

    Article  PubMed  CAS  Google Scholar 

  50. Metintas M, Ucgun I, Elbek O, Erginel S, Metintas S, Kolsuz M et al (2002) Computed tomography features in malignant pleural mesothelioma and other commonly seen pleural diseases. Eur J Radiol 41(1):1–9

    Article  PubMed  Google Scholar 

  51. Evans AL, Gleeson FV (2004) Radiology in pleural disease: state of the art. Respirology 9(3):300–312

    Article  PubMed  Google Scholar 

  52. Falaschi F, Battolla L, Mascalchi M, Cioni R, Zampa V, Lencioni R et al (1996) Usefulness of MR signal intensity in distinguishing benign from malignant pleural disease. AJR Am J Roentgenol 166(4):963–968

    Article  PubMed  CAS  Google Scholar 

  53. Sahn SA (2012) Getting the most from pleural fluid analysis. Respirology 17(2):270–277

    Article  PubMed  Google Scholar 

  54. Rahman NM, Mishra EK, Davies HE, Davies RJ, Lee YC (2008) Clinically important factors influencing the diagnostic measurement of pleural fluid pH and glucose. Am J Respir Crit Care Med 178(5):483–490

    Article  PubMed  CAS  Google Scholar 

  55. Fahim A, Kastelik JA (2010) The utility of pleural amylase measurement in metastatic mucinous adenocarcinoma. J R Coll Physicians Edinb 40(2):119–120

    Article  PubMed  CAS  Google Scholar 

  56. Rodriguez-Panadero F, Lopez MJ (1989) Low glucose and pH levels in malignant pleural effusions. Diagnostic significance and prognostic value in respect to pleurodesis. Am Rev Respir Dis 139(3):663–667

    PubMed  CAS  Google Scholar 

  57. Rodriguez-Panadero F, Lopez-Mejias J (1989) Survival time of patients with pleural metastatic carcinoma predicted by glucose and pH studies. Chest 95(2):320–324

    Article  PubMed  CAS  Google Scholar 

  58. Martinez-Garcia MA, Cases-Viedma E, Cordero-Rodriguez PJ, Hidalgo-Ramirez M, Perpina-Tordera M, Sanchis-Moret F et al (2000) Diagnostic utility of eosinophils in the pleural fluid. Eur Respir J 15(1):166–169

    Article  PubMed  CAS  Google Scholar 

  59. Ferreiro L, San Jose E, Gonzalez-Barcala FJ, Alvarez-Dobano JM, Golpe A, Gude F et al (2011) Eosinophilic pleural effusion: incidence, etiology and prognostic significance. Arch Bronconeumol 47(10):504–509

    Article  PubMed  Google Scholar 

  60. Oba Y, Abu-Salah T (2012) The prevalence and diagnostic significance of eosinophilic pleural effusions: a meta-analysis and systematic review. Respiration 83(3):198–208

    Article  PubMed  Google Scholar 

  61. Husain AN, Colby TV, Ordonez NG, Krausz T, Borczuk A, Cagle PT et al (2009) Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med 133(8):1317–1331

    PubMed  Google Scholar 

  62. Pinelli V, Laroumagne S, Sakr L, Marchetti GP, Tassi GF, Astoul P (2012) Pleural fluid cytological yield and visceral pleural invasion in patients with epithelioid malignant pleural mesothelioma. J Thorac Oncol 7(3):595–598

    Article  PubMed  Google Scholar 

  63. Agrawal V, Doelken P, Sahn SA (2008) Pleural fluid analysis in chylous pleural effusion. Chest 133(6):1436–1441

    Article  PubMed  Google Scholar 

  64. McGrath EE, Blades Z, Anderson PB (2010) Chylothorax: aetiology, diagnosis and therapeutic options. Respir Med 104(1):1–8

    Article  PubMed  Google Scholar 

  65. Huggins JT (2010) Chylothorax and cholesterol pleural effusion. Semin Respir Crit Care Med 31(6):743–750

    Article  PubMed  Google Scholar 

  66. Davies HE, Sadler RS, Bielsa S, Maskell NA, Rahman NM, Davies RJ et al (2009) Clinical impact and reliability of pleural fluid mesothelin in undiagnosed pleural effusions. Am J Respir Crit Care Med 180(5):437–444

    Article  PubMed  Google Scholar 

  67. Bielsa S, Esquerda A, Salud A, Montes A, Arellano E, Rodriguez-Panadero F et al (2009) High levels of tumor markers in pleural fluid correlate with poor survival in patients with adenocarcinomatous or squamous malignant effusions. Eur J Intern Med 20(4):383–386

    Article  PubMed  CAS  Google Scholar 

  68. Gaspar MJ, De Miguel J, Garcia Diaz JD, Diez M (2008) Clinical utility of a combination of tumour markers in the diagnosis of malignant pleural effusions. Anticancer Res 28(5B):2947–2952

    PubMed  CAS  Google Scholar 

  69. Creaney J, Robinson BW (2009) Serum and pleural fluid biomarkers for mesothelioma. Curr Opin Pulm Med 15(4):366–370

    Article  PubMed  CAS  Google Scholar 

  70. Creaney J, Francis RJ, Dick IM, Musk AW, Robinson BW, Byrne MJ et al (2011) Serum soluble mesothelin concentrations in malignant pleural mesothelioma: relationship to tumor volume, clinical stage and changes in tumor burden. Clin Cancer Res 17(5):1181–1189

    Article  PubMed  CAS  Google Scholar 

  71. Hollevoet K, Reitsma JB, Creaney J, Grigoriu BD, Robinson BW, Scherpereel A et al (2012) Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysis. J Clin Oncol 30(13):1541–1549

    Article  PubMed  Google Scholar 

  72. Porcel JM, Esquerda A, Rodriguez-Panadero F, Martinez-Iribarren A, Bielsa S (2011) The use of pleural fluid sCD44v6/std ratio for distinguishing mesothelioma from other pleural malignancies. J Thorac Oncol 6(1):190–194

    Article  PubMed  Google Scholar 

  73. van der Bij S, Schaake E, Koffijberg H, Burgers JA, de Mol BA, Moons KG (2011) Markers for the non-invasive diagnosis of mesothelioma: a systematic review. Br J Cancer 104(8):1325–1333

    Article  PubMed  CAS  Google Scholar 

  74. Hooper CE, Elvers KT, Welsh GI, Millar AB, Maskell NA (2012) VEGF and sVEGFR-1 in malignant pleural effusions: association with survival and pleurodesis outcomes. Lung Cancer 77(2):443–449

    Article  PubMed  CAS  Google Scholar 

  75. Sriram KB, Relan V, Clarke BE, Duhig EE, Yang IA, Bowman RV et al (2011) Diagnostic molecular biomarkers for malignant pleural effusions. Future Oncol 7(6):737–752

    Article  PubMed  Google Scholar 

  76. Garcia LW, Ducatman BS, Wang HH (1994) The value of multiple fluid specimens in the cytological diagnosis of malignancy. Mod Pathol 7(6):665–668

    PubMed  CAS  Google Scholar 

  77. Swiderek J, Morcos S, Donthireddy V, Surapaneni R, Jackson-Thompson V, Schultz L et al (2010) Prospective study to determine the volume of pleural fluid required to diagnose malignancy. Chest 137(1):68–73

    Article  PubMed  Google Scholar 

  78. Dekker A, Bupp PA (1978) Cytology of serous effusions. An investigation into the usefulness of cell blocks versus smears. Am J Clin Pathol 70(6):855–860

    PubMed  CAS  Google Scholar 

  79. Nguyen KS, Neal JW (2012) First-line treatment of EGFR-mutant non-small-cell lung cancer: the role of erlotinib and other tyrosine kinase inhibitors. Biologics 6:337–344

    PubMed  CAS  Google Scholar 

  80. Gridelli C, Ciardiello F, Gallo C, Feld R, Butts C, Gebbia V et al (2012) First-line erlotinib followed by second-line cisplatin-gemcitabine chemotherapy in advanced non-small-cell lung cancer: the TORCH randomized trial. J Clin Oncol 30(24):3002–3011

    Article  PubMed  CAS  Google Scholar 

  81. Salyer WR, Eggleston JC, Erozan YS (1975) Efficacy of pleural needle biopsy and pleural fluid cytopathology in the diagnosis of malignant neoplasm involving the pleura. Chest 67(5):536–539

    Article  PubMed  CAS  Google Scholar 

  82. Escudero BC, Garcia CM, Cuesta CB, Molinos ML, Rodriguez RS, Gonzalez PA et al (1990) Cytologic and bacteriologic analysis of fluid and pleural biopsy specimens with Cope’s needle. Study of 414 patients. Arch Intern Med 150(6):1190–1194

    Article  Google Scholar 

  83. Frist B, Kahan AV, Koss LG (1979) Comparison of the diagnostic values of biopsies of the pleura and cytologic evaluation of pleural fluids. Am J Clin Pathol 72(1):48–51

    PubMed  CAS  Google Scholar 

  84. Chen NH, Hsieh IC, Tsao TC (1997) Comparison of the clinical diagnostic value between pleural needle biopsy and analysis of pleural effusion. Changgeng Yi Xue Za Zhi 20(1):11–16

    PubMed  CAS  Google Scholar 

  85. Prakash UB, Reiman HM (1985) Comparison of needle biopsy with cytologic analysis for the evaluation of pleural effusion: analysis of 414 cases. Mayo Clin Proc 60(3):158–164

    Article  PubMed  CAS  Google Scholar 

  86. Von Hoff DD, LiVolsi V (1975) Diagnostic reliability of needle biopsy of the parietal pleura. A review of 272 biopsies. Am J Clin Pathol 64(2):200–203

    Google Scholar 

  87. Salyer WR, Eggleston JC, Erozan YS (1980) Comparison of the diagnostic values of pleural biopsies and cytologic evaluation of pleural fluids. Am J Clin Pathol 73(2):289

    PubMed  CAS  Google Scholar 

  88. Maskell NA, Gleeson FV, Davies RJ (2003) Standard pleural biopsy versus CT-guided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: a randomised controlled trial. Lancet 361(9366):1326–1330

    Article  PubMed  CAS  Google Scholar 

  89. Adams RF, Gray W, Davies RJ, Gleeson FV (2001) Percutaneous image-guided cutting needle biopsy of the pleura in the diagnosis of malignant mesothelioma. Chest 120(6):1798–1802

    Article  PubMed  CAS  Google Scholar 

  90. Rahman NM, Ali NJ, Brown G, Chapman SJ, Davies RJ, Downer NJ et al (2010) Local anaesthetic thoracoscopy: British Thoracic Society Pleural Disease Guideline 2010. Thorax 65(Suppl 2):ii54–ii60

    Article  PubMed  Google Scholar 

  91. Rodriguez-Panadero F (2008) Medical thoracoscopy. Respiration 76(4):363–372

    Article  PubMed  Google Scholar 

  92. Rodriguez-Panadero F, Janssen JP, Astoul P (2006) Thoracoscopy: general overview and place in the diagnosis and management of pleural effusion. Eur Respir J 28(2):409–422

    Article  PubMed  CAS  Google Scholar 

  93. Yim AP, Izzat MB, Lee TW, Wan S (1999) Video-assisted thoracic surgery: a renaissance in surgical therapy. Respirology 4(1):1–8

    Article  PubMed  CAS  Google Scholar 

  94. Froudarakis ME, Noppen M (2009) Medical thoracoscopy: new tricks for an old trade. Respiration 78(4):373–374

    Article  PubMed  Google Scholar 

  95. Froudarakis ME (2011) New challenges in medical thoracoscopy. Respiration 82(2):197–200

    Article  PubMed  Google Scholar 

  96. Munavvar M, Khan MA, Edwards J, Waqaruddin Z, Mills J (2007) The autoclavable semirigid thoracoscope: the way forward in pleural disease? Eur Respir J 29(3):571–574

    Article  PubMed  CAS  Google Scholar 

  97. Lee P, Hsu A, Lo C, Colt HG (2007) Prospective evaluation of flex-rigid pleuroscopy for indeterminate pleural effusion: accuracy, safety and outcome. Respirology 12(6):881–886

    Article  PubMed  Google Scholar 

  98. Tassi GF, Davies RJ, Noppen M (2006) Advanced techniques in medical thoracoscopy. Eur Respir J 28(5):1051–1059

    Article  PubMed  CAS  Google Scholar 

  99. Tassi GF, Marchetti GP, Aliprandi PL (2011) Advanced medical thoracoscopy. Monaldi Arch Chest Dis 75(1):99–101

    PubMed  CAS  Google Scholar 

  100. Tassi G, Marchetti G (2003) Minithoracoscopy: a less invasive approach to thoracoscopy. Chest 124(5):1975–1977

    Article  PubMed  Google Scholar 

  101. Greillier L, Cavailles A, Fraticelli A, Scherpereel A, Barlesi F, Tassi G et al (2007) Accuracy of pleural biopsy using thoracoscopy for the diagnosis of histologic subtype in patients with malignant pleural mesothelioma. Cancer 110(10):2248–2252

    Article  PubMed  Google Scholar 

  102. Kolschmann S, Ballin A, Gillissen A (2005) Clinical efficacy and safety of thoracoscopic talc pleurodesis in malignant pleural effusions. Chest 128(3):1431–1435

    Article  PubMed  Google Scholar 

  103. Gondker A, Pathmanathan S, Kastelik J (2011) Practical procedures: chemical pleurodesis—what is it & how to do it. Found Years J 5(9):88–92

    Google Scholar 

  104. Rodriguez-Panadero F, Montes-Worboys A (2012) Mechanisms of pleurodesis. Respiration 83(2):91–98

    Article  PubMed  Google Scholar 

  105. Rodriguez-Panadero F, Segado A, Martin JJ, Ayerbe R, Torres GI, Castillo J (1995) Failure of talc pleurodesis is associated with increased pleural fibrinolysis. Am J Respir Crit Care Med 151(3 Pt 1):785–790

    PubMed  CAS  Google Scholar 

  106. Schwarz Y, Star A (2012) Role of talc modulation on cytokine activation in cancer patients undergoing pleurodesis. Pulm Med 2012:806183. Epub 2012 Mar 7

  107. Maskell NA, Lee YC, Gleeson FV, Hedley EL, Pengelly G, Davies RJ (2004) Randomized trials describing lung inflammation after pleurodesis with talc of varying particle size. Am J Respir Crit Care Med 170(4):377–382

    Article  PubMed  Google Scholar 

  108. Fraticelli A, Robaglia-Schlupp A, Riera H, Monjanel-Mouterde S, Cau P, Astoul P (2002) Distribution of calibrated talc after intrapleural administration: an experimental study in rats. Chest 122(5):1737–1741

    Article  PubMed  Google Scholar 

  109. Maceachern P, Tremblay A (2011) Pleural controversy: pleurodesis versus indwelling pleural catheters for malignant effusions. Respirology 16(5):747–754

    Article  PubMed  Google Scholar 

  110. Davies HE, Mishra EK, Kahan BC, Wrightson JM, Stanton AE, Guhan A et al (2012) Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial. JAMA 307(22):2383–2389

    PubMed  CAS  Google Scholar 

  111. Spiegler PA, Hurewitz AN, Groth ML (2003) Rapid pleurodesis for malignant pleural effusions. Chest 123(6):1895–1898

    Article  PubMed  Google Scholar 

  112. Goodman A, Davies CW (2006) Efficacy of short-term versus long-term chest tube drainage following talc slurry pleurodesis in patients with malignant pleural effusions: a randomised trial. Lung Cancer 54(1):51–55

    Article  PubMed  Google Scholar 

  113. Bielsa S, Hernandez P, Rodriguez-Panadero F, Taberner T, Salud A, Porcel JM (2011) Tumor type influences the effectiveness of pleurodesis in malignant effusions. Lung 189(2):151–155

    Article  PubMed  Google Scholar 

  114. Dresler CM, Olak J, Herndon JE, Richards WG, Scalzetti E, Fleishman SB et al (2005) Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest 127(3):909–915

    Article  PubMed  Google Scholar 

  115. Janssen JP, Collier G, Astoul P, Tassi GF, Noppen M, Rodriguez-Panadero F et al (2007) Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study. Lancet 369(9572):1535–1539

    Article  PubMed  Google Scholar 

  116. Huggins JT, Sahn SA, Heidecker J, Ravenel JG, Doelken P (2007) Characteristics of trapped lung: pleural fluid analysis, manometry, and air-contrast chest CT. Chest 131(1):206–213

    Article  PubMed  Google Scholar 

  117. Puri V, Pyrdeck TL, Crabtree TD, Kreisel D, Krupnick AS, Colditz GA et al (2012) Treatment of malignant pleural effusion: a cost-effectiveness analysis. Ann Thorac Surg 94(2):374–380

    Article  PubMed  Google Scholar 

  118. Tremblay A, Mason C, Michaud G (2007) Use of tunnelled catheters for malignant pleural effusions in patients fit for pleurodesis. Eur Respir J 30(4):759–762

    Article  PubMed  CAS  Google Scholar 

  119. Tremblay A, Michaud G (2006) Single-center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion. Chest 129(2):362–368

    Article  PubMed  Google Scholar 

  120. Bibby AC, Maskell NA (2011) Pleural procedures: intercostal chest drains and indwelling pleural catheters. Br J Hosp Med (Lond) 72(6):331–335

    Google Scholar 

  121. Van Meter ME, McKee KY, Kohlwes RJ (2011) Efficacy and safety of tunneled pleural catheters in adults with malignant pleural effusions: a systematic review. J Gen Intern Med 26(1):70–76

    Article  PubMed  Google Scholar 

  122. Putnam JB Jr, Light RW, Rodriguez RM, Ponn R, Olak J, Pollak JS et al (1999) A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions. Cancer 86(10):1992–1999

    Article  PubMed  Google Scholar 

  123. Demmy TL, Gu L, Burkhalter JE, Toloza EM, D’Amico TA, Sutherland S et al (2012) Optimal management of malignant pleural effusions (results of CALGB 30102). J Natl Compr Canc Netw 10(8):975–982

    PubMed  Google Scholar 

  124. Reddy C, Ernst A, Lamb C, Feller-Kopman D (2011) Rapid pleurodesis for malignant pleural effusions: a pilot study. Chest 139(6):1419–1423

    Article  PubMed  Google Scholar 

  125. Zarogoulidis P, Chatzaki E, Hohenforst-Schmidt W, Goldberg EP, Galaktidou G, Kontakiotis T et al (2012) Management of malignant pleural effusion by suicide gene therapy in advanced stage lung cancer: a case series and literature review. Cancer Gene Ther 19(9):593–600

    Article  PubMed  CAS  Google Scholar 

  126. Morgensztern D, Waqar S, Subramanian J, Trinkaus K, Govindan R (2012) Prognostic impact of malignant pleural effusion at presentation in patients with metastatic non-small-cell lung cancer. J Thorac Oncol 7(10):1485–1489

    Article  PubMed  Google Scholar 

  127. Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN (2007) Overview of resistance to systemic therapy in patients with breast cancer. Adv Exp Med Biol 608:1–22

    Article  PubMed  CAS  Google Scholar 

  128. Rastelli F, Crispino S (2008) Factors predictive of response to hormone therapy in breast cancer. Tumori 94(3):370–383

    PubMed  Google Scholar 

  129. Hind D, Ward S, De Nigris E, Simpson E, Carroll C, Wyld L (2007) Hormonal therapies for early breast cancer: systematic review and economic evaluation. Health Technol Assess 11(26):iii–xi

    PubMed  CAS  Google Scholar 

  130. El Saghir NS, Tfayli A, Hatoum HA, Nachef Z, Dinh P, Awada A (2011) Treatment of metastatic breast cancer: state-of-the-art, subtypes and perspectives. Crit Rev Oncol Hematol 80(3):433–449

    Article  PubMed  Google Scholar 

  131. Barton S, Swanton C (2011) Recent developments in treatment stratification for metastatic breast cancer. Drugs 71(16):2099–2113

    Article  PubMed  CAS  Google Scholar 

  132. Carey LA (2010) Directed therapy of subtypes of triple-negative breast cancer. Oncologist 15(Suppl 5):49–56

    Article  PubMed  CAS  Google Scholar 

  133. Santos GT, Prolla JC, Camillo ND, Zavalhia LS, Ranzi AD, Bica CG (2012) Clinical and pathological factors influencing the survival of breast cancer patients with malignant pleural effusion. J Bras Pneumol 38(4):487–493

    Article  PubMed  Google Scholar 

  134. Koo JS, Jung W, Jeong J (2010) Metastatic breast cancer shows different immunohistochemical phenotype according to metastatic site. Tumori 96(3):424–432

    PubMed  Google Scholar 

  135. Pokieser W, Cassik P, Fischer G, Vesely M, Ulrich W, Peters-Engl C (2004) Malignant pleural and pericardial effusion in invasive breast cancer: impact of the site of the primary tumor. Breast Cancer Res Treat 83(2):139–142

    Article  PubMed  CAS  Google Scholar 

  136. Kido H, Morizane C, Tamura T, Hagihara A, Kondo S, Ueno H et al (2012) Gemcitabine-induced pleuropericardial effusion in a patient with pancreatic cancer. Jpn J Clin Oncol 42(9):845–850

    Article  PubMed  Google Scholar 

  137. Whitworth JM, Schneider KE, Fauci JM, Bryant AS, Cerfolio RJ, Straughn JM Jr (2012) Outcomes of patients with gynecologic malignancies undergoing video-assisted thoracoscopic surgery (VATS) and pleurodesis for malignant pleural effusion. Gynecol Oncol 125(3):646–648

    Article  PubMed  Google Scholar 

  138. Hirata T, Yonemori K, Hirakawa A, Shimizu C, Tamura K, Ando M et al (2011) Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients. Eur Respir J 38(6):1425–1430

    Article  PubMed  CAS  Google Scholar 

  139. Treasure T, Sedrakyan A (2004) Pleural mesothelioma: little evidence, still time to do trials. Lancet 364(9440):1183–1185

    Article  PubMed  Google Scholar 

  140. van Ruth S, Baas P, Zoetmulder FA (2003) Surgical treatment of malignant pleural mesothelioma: a review. Chest 123(2):551–561

    Article  PubMed  Google Scholar 

  141. Bolukbas S, Manegold C, Eberlein M, Bergmann T, Fisseler-Eckhoff A, Schirren J (2011) Survival after trimodality therapy for malignant pleural mesothelioma: Radical Pleurectomy, chemotherapy with cisplatin/pemetrexed and radiotherapy. Lung Cancer 71(1):75–81

    Article  PubMed  Google Scholar 

  142. Flores RM (2009) Surgical options in malignant pleural mesothelioma: extrapleural pneumonectomy or pleurectomy/decortication. Semin Thorac Cardiovasc Surg 21(2):149–153

    Article  PubMed  Google Scholar 

  143. Zauderer MG, Krug LM (2011) The evolution of multimodality therapy for malignant pleural mesothelioma. Curr Treat Options Oncol 12(2):163–172

    Article  PubMed  Google Scholar 

  144. Treasure T, Lang-Lazdunski L, Waller D, Bliss JM, Tan C, Entwesle J, Snee M, O’Brien M, Thomas G et al (2011) Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study. Lancet Oncol 2(8):763–772

    Article  Google Scholar 

  145. Flores RM, Pass HI, Seshan VE, Dycoco J, Zakowski M, Carbone M et al (2008) Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. J Thorac Cardiovasc Surg 135(3):620–626

    Article  PubMed  Google Scholar 

  146. Kaifi JT, Toth JW, Gusani NJ, Kimchi ET, Staveley-O’Carroll KF, Belani CP et al (2012) Multidisciplinary management of malignant pleural effusion. J Surg Oncol 105(7):731–738

    Article  PubMed  Google Scholar 

  147. Morel A, Mishra E, Medley L, Rahman NM, Wrightson J, Talbot D et al (2011) Chemotherapy should not be withheld from patients with an indwelling pleural catheter for malignant pleural effusion. Thorax 66(5):448–449

    Article  PubMed  Google Scholar 

  148. Gompelmann D, Eberhardt R, Herth FJ (2011) Advanced malignant lung disease: what the specialist can offer. Respiration 82(2):111–123

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Respiratory Medicine, Hull and East Yorkshire Hospitals NHS Trust, Hull York Medical School, Castle Hill Hospital, University of Hull, Castle Road, Cottingham, East Yorkshire, HU16 5JQ, UK

    Jack A. Kastelik

Authors
  1. Jack A. Kastelik
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jack A. Kastelik.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kastelik, J.A. Management of Malignant Pleural Effusion. Lung 191, 165–175 (2013). https://doi.org/10.1007/s00408-012-9445-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00408-012-9445-1

Keywords

Search

Navigation